Japan Tissue Engineering Co., Ltd.
7774
Rank in Stocks
#17315
Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine... Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine sector in Japan. The company's activities are organized into three core divisions: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It manufactures and delivers autologous cultured tissues, such as epidermis, cartilage, corneal epithelium, and oral mucosal epithelium, to medical institutions for therapeutic applications. The firm also produces other advanced tissue-engineered medical products. Furthermore, Japan Tissue Engineering is involved in the research and development of three-dimensional human cultured tissue models, which are utilized in the development of external-use cosmetics and drugs, as well as for scientific investigations concerning skin and corneal tissues. Additionally, the company provides comprehensive contract development and manufacturing services for regenerative medicine. Established in 1999, Japan Tissue Engineering Co., Ltd. is based in Gamagori, Japan, and functions as a subsidiary of Teijin Limited.
Share Price
$4.27
Last synced: 2026-11-10
Market Cap
$173.51M
Change (1 day)
6.47%
Change (1 year)
41.25%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Japan Tissue Engineering Co., Ltd. (7774)
Category
Healthcare
Operating Margin for Japan Tissue Engineering Co., Ltd. (7774)
Operating Margin as of November 2026 TTM: -9.74%
According to Japan Tissue Engineering Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -9.74%. At the end of 2025 the company had an operating margin of -9.71%.
Operating Margin history for Japan Tissue Engineering Co., Ltd. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -9.74% | 0.31% |
| 2025 | -9.71% | -268.87% |
| 2024 | 5.75% | -116.05% |
| 2023 | -35.82% | 51.27% |
| 2022 | -23.68% | 14.51% |
| 2021 | -20.68% | 103.14% |
| 2020 | -10.18% | -31.36% |
| 2019 | -14.83% | -259.29% |
| 2018 | 9.31% | -36.36% |
| 2017 | 14.63% | -128.97% |
| 2016 | -50.50% | -26.92% |
| 2015 | -69.10% | -32.08% |
| 2014 | -101.73% | -48.01% |
| 2013 | -195.68% | 6.50% |
| 2012 | -183.73% | -29.05% |
| 2011 | -258.95% | -39.64% |
| 2010 | -428.98% | -46.67% |
| 2009 | -804.35% | 9.33% |
| 2008 | -735.73% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -103.96% |
US
|
|
| -149.01% | -84.70% |
US
|
|
| 25.57% | -102.63% |
AU
|
|
| 31.23% | -103.21% |
BE
|
|
| 29.35% | -103.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Japan Tissue Engineering Co., Ltd.'s operating margin
What is Japan Tissue Engineering Co., Ltd.'s operating margin?
Japan Tissue Engineering Co., Ltd.'s operating margin is -9.74%, as of Nov 2026.
What was Japan Tissue Engineering Co., Ltd.'s operating margin in 2025?
In 2025, Japan Tissue Engineering Co., Ltd.'s operating margin was -9.71%, compared with 5.75% in 2024.
How has Japan Tissue Engineering Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Japan Tissue Engineering Co., Ltd.'s operating margin was highest in 2024 (5.75%) and lowest in 2023 (-35.82%).
How does Japan Tissue Engineering Co., Ltd.'s operating margin compare with similar companies?
Japan Tissue Engineering Co., Ltd.'s operating margin (-9.74%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.